|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
125,280,000 |
Market
Cap: |
5.48(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$3.16 - $47.08 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 20.8 |
Insider 6 Months : 24.2 |
Insider 3/6 Months : 45.4 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Corbus Pharmaceuticals Holdings is focused on the development of immune modulators that will have application in disease states spanning from immuno-oncology to fibrosis. Co.'s pipeline includes anti-integrin monoclonal antibodies that block activation of Transforming growth factor B (TGFB) and small molecules that activate or inhibit the endocannabinoid system. Co.'s pipeline includes: anti-integrin monoclonal antibodies for the treatment of cancer and fibrosis that inhibit the activation of TGFB; cannabinoid receptor type 1 inverse agonists designed to treat obesity and related metabolic diseases; and lenabasum, a synthetic, oral molecule that activates cannabinoid receptor type 2.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
550,000 |
1,582,632 |
1,582,632 |
1,633,932 |
Total Buy Value |
$23,327,560 |
$46,689,501 |
$46,689,501 |
$46,703,200 |
Total People Bought |
1 |
2 |
2 |
5 |
Total Buy Transactions |
2 |
4 |
4 |
9 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cohen Yuval |
Chief Executive Officer |
|
2014-12-17 |
4 |
B |
$3.66 |
$1,464 |
D/D |
400 |
1,900 |
2.73 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2014-12-11 |
4 |
B |
$3.98 |
$3,980 |
D/D |
1,000 |
9,700 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2014-12-09 |
4 |
B |
$3.97 |
$6,764 |
D/D |
1,700 |
8,700 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2014-12-04 |
4 |
B |
$3.00 |
$9,900 |
D/D |
3,300 |
59,612 |
2.74 |
- |
|
Gupta Renu |
Director |
|
2014-12-04 |
4 |
B |
$3.00 |
$15,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2014-12-04 |
4 |
B |
$3.30 |
$1,650 |
D/D |
500 |
1,500 |
2.73 |
- |
|
Hochman David P |
Director |
|
2014-12-04 |
4 |
B |
$3.05 |
$3,965 |
D/D |
1,300 |
443,300 |
2.31 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2014-12-04 |
4 |
B |
$3.15 |
$6,400 |
D/D |
2,000 |
7,000 |
2.74 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2014-12-03 |
4 |
B |
$3.20 |
$3,200 |
D/D |
1,000 |
1,000 |
2.73 |
- |
|
Hochman David P |
Director |
|
2014-12-02 |
4 |
B |
$3.25 |
$3,050 |
D/D |
900 |
442,000 |
2.31 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2014-12-02 |
4 |
B |
$3.03 |
$3,030 |
D/D |
1,000 |
5,000 |
2.66 |
- |
|
White Barbara |
Chief Medical Officer |
|
2014-12-01 |
4 |
B |
$3.00 |
$49,344 |
D/D |
16,448 |
56,312 |
2.74 |
- |
|
Hochman David P |
Director |
|
2014-12-01 |
4 |
B |
$4.00 |
$2,000 |
D/D |
500 |
441,100 |
2.31 |
- |
|
White Barbara |
Chief Medical Officer |
|
2014-11-28 |
4 |
B |
$3.00 |
$59,799 |
D/D |
19,933 |
39,864 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2014-11-26 |
4 |
B |
$3.00 |
$40,200 |
D/D |
13,400 |
19,931 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2014-11-26 |
4 |
B |
$3.05 |
$3,050 |
D/D |
1,000 |
4,000 |
2.66 |
- |
|
Hochman David P |
Director |
|
2014-11-25 |
4 |
B |
$3.08 |
$6,165 |
D/D |
2,000 |
440,600 |
2.39 |
- |
|
Tepper Mark |
President and CSO |
|
2014-11-25 |
4 |
B |
$3.05 |
$6,100 |
D/D |
2,000 |
2,101,000 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2014-11-25 |
4 |
B |
$3.00 |
$9,150 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2014-11-25 |
4 |
B |
$3.03 |
$19,789 |
D/D |
6,531 |
6,531 |
2.74 |
- |
|
Knoll Capital Management, Lp |
10% Owner |
|
2014-11-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,750,000 |
|
- |
|
Burstein Sumner |
10% Owner |
|
2014-11-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,825,546 |
|
- |
|
Tepper Mark |
President and CSOOfficer |
|
2014-11-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,099,000 |
|
- |
|
Holmer Alan F |
Director |
|
2014-11-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
Hochman David P |
Director |
|
2014-11-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
152,900 |
|
- |
|
176 Records found
|
|
Page 7 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|